Posts

NRAS Mutations in Cancer: Gene Function, Oncogenic Signaling, and Clinically Relevant Variants

Image
NRAS (neuroblastoma RAS viral oncogene homolog) is one of the three members of the RAS proto-oncogene family, together with HRAS and KRAS. It encodes a small GTPase protein with a molecular weight of approximately 21 kDa, which plays a central role in transmitting signaling pathways involved in cell proliferation, differentiation, and survival. RAS family genes represent some of the most frequently mutated oncogenes in human cancers. Comprehensive analyses estimate that approximately 19% of cancer patients harbor mutations in at least one RAS gene, with KRAS mutations being the most prevalent, followed by NRAS and HRAS mutations. Compared with KRAS, NRAS mutations exhibit a more restricted distribution among specific tumor types, with particularly high frequencies observed in melanoma, multiple myeloma, and acute myeloid leukemia (AML). NRAS mutations typically result in constitutive activation of the N-Ras protein, leading to persistent activation of key downstream signaling pathways,...

G6PD Deficiency and Oxidative Stress: Gene Function, Disease Mechanisms, and Clinically Relevant Variants

Image
What is G6PD? An Overview of the Gene, Enzyme, and Oxidative Stress Pathway Glucose-6-phosphate dehydrogenase (G6PD) is a critical metabolic enzyme encoded by the G6PD gene. It functions as the first and rate-limiting enzyme in the pentose phosphate pathway (PPP), a metabolic route that serves as a central hub for cellular antioxidant defense and nucleotide synthesis. G6PD catalyzes the oxidation of glucose-6-phosphate, generating two essential products: NADPH, the primary source of reducing power for cellular redox balance, and ribose-5-phosphate, a key precursor for nucleotide biosynthesis. NADPH is indispensable for regenerating reduced glutathione (GSH), which directly determines a cell’s ability to neutralize oxidative stress. Consequently, proper G6PD activity is essential for maintaining erythrocyte integrity and supports the unique metabolic demands of tumor cells. The G6PD gene is located on the X chromosome (Xq28). More than 230 point mutations have been identified, and appro...

How Lipoprotein Particles Shape Lipid Metabolism and Disease: From Cellular Response Mechanisms to CRISPR KO Models

Image
  When the metabolic balance of lipoprotein particles in the blood is disrupted, it triggers chronic inflammation—the common root of atherosclerosis, metabolic syndrome, and even neurodegenerative diseases. Circulating lipoprotein particles are the primary carriers of cholesterol and triglycerides: low-density lipoprotein (LDL) delivers cholesterol to tissues, while high-density lipoprotein (HDL) recycles it via reverse transport. Together, they maintain the delicate balance of lipid metabolism. When this balance is broken—such as through oxidative deposition of LDL or dysfunction of HDL—damage-associated molecular patterns (DAMPs) like oxidized phospholipids (OxPLs) activate innate immune signaling, driving foam cell formation and metabolic inflammation. Pathway enrichment analysis shows that lipoprotein response pathways are significantly enriched in functional genomics (FDR = 1.11×10⁻⁵), further confirming their role as key regulatory hubs. With CRISPR gene editing technology, i...

Response to Lipoprotein Particle Pathway KO Cell Lines

Image
Overview of the Lipoprotein Response Pathway What is the Lipoprotein Response? The Response to Lipoprotein Particle Pathway refers to the key biological processes by which cells or organisms react to stimulation by lipoprotein particles such as LDL, HDL, and VLDL (Gene Ontology term: GO:0055094). Lipoproteins are responsible for transporting lipids, including cholesterol, triglycerides, and phospholipids, through the bloodstream. Maintaining their metabolic homeostasis is essential for cellular function, energy balance, and endocrine regulation. Disruption of lipoprotein metabolism can directly lead to major metabolic diseases, including atherosclerosis, hyperlipidemia, non-alcoholic fatty liver disease (NAFLD), obesity, and type 2 diabetes. Regulatory Network of the Lipoprotein Response The Response to Lipoprotein Particle Pathway regulates multiple biological processes, including lipid uptake, inflammatory responses, cholesterol homeostasis, and innate immune signaling. When lipoprot...

KRAS Mutant Cell Lines for Precision Oncology: From Allele-Specific Signaling to Targeted Therapy Resistance

Image
KRAS is one of the most frequently mutated oncogenes in human cancers, yet different mutation subtypes (G12C, G12D, G12V, G13D, etc.) exhibit significant differences in oncogenic potential, signaling pathway preferences, and drug sensitivity. The approval of the first G12C inhibitor in 2021 ushered in a new era of precision targeting of KRAS. Understanding allele-specific functions, screening sensitive drugs, and dissecting resistance mechanisms all rely on isogenic cell models with consistent genetic backgrounds. This article systematically reviews the clinical significance and therapeutic breakthroughs of major KRAS mutation subtypes, and introduces EDITGENE’s off-the-shelf cell lines with KRAS point mutation in HCT116 and LLC, built on the Bingo™ PE7 platform .  These ready-to-ship cell lines provide academic institutes and pharmaceutical companies with ideal tools ranging from in vitro screening to in vivo efficacy evaluation. KRAS mutation spectrum: heterogeneous distribution...

Mitophagy Mechanisms in Disease: PINK1/Parkin and BNIP3/NIX Pathways

Image
  Mitochondrial autophagy, also known as mitophagy, is a selective form of autophagy that specifically removes damaged or superfluous mitochondria from cells. It plays a central role in maintaining mitochondrial quality control, reducing the accumulation of reactive oxygen species (ROS), and regulating cellular energy metabolism and homeostasis. In recent years, a growing body of research has demonstrated that dysregulation of mitophagy is closely associated with a wide range of diseases, including neurodegenerative disorders, cancer, cardiovascular diseases, and metabolic dysfunction. Therefore, systematically elucidating its molecular mechanisms and validating its functions using precise models has become a major focus of current research. Mechanisms of Mitophagy At its core, mitophagy involves the sequestration of specific mitochondria by autophagosomes, followed by their delivery to lysosomes for degradation. This process typically includes several key steps: ● Damage recogniti...